Immediate Impact
1 from Science/Nature 42 standout
Citing Papers
Liquid biopsy in cancer: current status, challenges and future prospects
2024 Standout
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
2024 Standout
Works of Hanfei Guo being referenced
Coexisting opportunities and challenges: In which scenarios can minimal/measurable residual disease play a role in advanced non-small cell lung cancer?
2021
[Advances in Combination Therapy of Immune Checkpoint Inhibitors for Lung Cancer].
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Hanfei Guo | 113 | 76 | 46 | 128 | 20 | 308 | |
| Xusheng Chang | 116 | 98 | 66 | 111 | 19 | 354 | |
| Mei Wang | 158 | 70 | 53 | 104 | 26 | 348 | |
| Shengyu Wu | 119 | 67 | 67 | 137 | 26 | 314 | |
| Alain Chaunavel | 64 | 69 | 55 | 101 | 16 | 288 | |
| Andrey S. Bryukhovetskiy | 111 | 54 | 41 | 108 | 29 | 341 | |
| Kai Zhang | 121 | 54 | 62 | 112 | 26 | 317 | |
| Srinivasa R. Rao | 77 | 51 | 82 | 121 | 17 | 312 | |
| Junko Zenkoh | 69 | 40 | 43 | 132 | 18 | 326 | |
| Haigang Geng | 64 | 66 | 62 | 122 | 18 | 255 | |
| Huirong Ding | 107 | 50 | 76 | 172 | 22 | 364 |
All Works
Login with ORCID to disown or claim papers
Loading papers...